These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10197497)
1. Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer. Lau GK; Yuen ST; Au WY; Wu PC; Liang R J Gastroenterol Hepatol; 1999 Mar; 14(3):262-8. PubMed ID: 10197497 [TBL] [Abstract][Full Text] [Related]
2. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. Lau GK; Liang R; Wu PC; Lee CK; Lim WL; Au WY J Hepatol; 1998 Mar; 28(3):359-68. PubMed ID: 9551671 [TBL] [Abstract][Full Text] [Related]
3. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B associated liver failure following bone marrow transplantation. Caselitz M; Link H; Hein R; Maschek H; Böker K; Poliwoda H; Manns MP J Hepatol; 1997 Sep; 27(3):572-7. PubMed ID: 9314136 [TBL] [Abstract][Full Text] [Related]
5. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels. Wiegand J; Wedemeyer H; Finger A; Heidrich B; Rosenau J; Michel G; Bock CT; Manns MP; Tillmann HL Antivir Ther; 2008; 13(4):547-54. PubMed ID: 18672533 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [TBL] [Abstract][Full Text] [Related]
7. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive. Lau GK; Liang R; Lee CK; Yuen ST; Hou J; Lim WL; Williams R J Infect Dis; 1998 Dec; 178(6):1585-91. PubMed ID: 9815208 [TBL] [Abstract][Full Text] [Related]
8. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. Shapira R; Mor E; Bar-Nathan N; Sokal EM; Tur-Kaspa R; Dinari G; Ben-Ari Z Transplantation; 2001 Jul; 72(2):333-6. PubMed ID: 11477362 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir]. Wang HF; Li L; Su HB; Ji W Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):180-2. PubMed ID: 12870005 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. Liang R; Lau GK; Kwong YL J Clin Oncol; 1999 Jan; 17(1):394-8. PubMed ID: 10458258 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy. Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446 [TBL] [Abstract][Full Text] [Related]
14. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Ilan Y; Nagler A; Adler R; Tur-Kaspa R; Slavin S; Shouval D Gastroenterology; 1993 Jun; 104(6):1818-21. PubMed ID: 8500741 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B. Cheng PN; Tsai HW; Chiu YC; Ho CH; Wu IC; Chang TT J Clin Virol; 2013 Aug; 57(4):323-30. PubMed ID: 23731848 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy. Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Locasciulli A; Bacigalupo A; Van Lint MT; Chemello L; Pontisso P; Occhini D; Uderzo C; Shulman HM; Portmann B; Marmont AM Bone Marrow Transplant; 1990 Jul; 6(1):25-9. PubMed ID: 2390630 [TBL] [Abstract][Full Text] [Related]
18. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors. Ilan Y; Nagler A; Shouval D; Ackerstein A; Or R; Kapelushnik J; Adler R; Slavin S Clin Exp Immunol; 1994 Aug; 97(2):299-302. PubMed ID: 8050180 [TBL] [Abstract][Full Text] [Related]
19. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study. Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lau EHY; Cheung KS; Lie AKW; Lai CL; Kwong YL; Yuen MF Hepatology; 2017 May; 65(5):1451-1461. PubMed ID: 28027590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]